RELMADA THERAPEUTICS, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -60.4% | -60.4% | -56.3% |
| FY2022 | -111.8% | -111.8% | -102.7% |
| FY2023 | -115.7% | -115.7% | -101.3% |
| FY2024 | -225.2% | -225.2% | -174.6% |
| FY2025 | -66.3% | -66.3% | -61.0% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -60.4% | -60.4% | -56.3% |
| FY2022 | -111.8% | -111.8% | -102.7% |
| FY2023 | -115.7% | -115.7% | -101.3% |
| FY2024 | -225.2% | -225.2% | -174.6% |
| FY2025 | -66.3% | -66.3% | -61.0% |